Sentence examples for available ibd from inspiring English sources

To our knowledge, however, the present study is the first meta-analysis for all available IBD serological markers.

Virus strains used included the commercially available IBD vaccine strain D78 and the virulent strain DK01, previously described [ 26].

A clinical case-note audit was performed reviewing over 300 of the available IBD patient files as described elsewhere [ 9].

The currently available IBD serological markers are: ASCA (anti-Saccharomyces cerevisiae antibody) [25] [31], pANCA (perinuclear anti-neutrophil antibody) [25] [30], [32], and anti-OmpC (antibody against outer membrane porin C of E.coli) [28], [33] [37].

While the service is available to all IB recipients in participating GP practices, GPs use their discretion to refer patients to PAS; referral criteria are broad and it is left to the GPs' discretion to decide who is referred.

The MPRs of medications on the core list of IBs available in both sectors were generally higher in the public sector than in the private sector (median MPRs were 6.78 and 4.13 for the public and private sectors, respectively).

ACR20, ACR50 and ACR70 response rates in patients treated with these rituximab doses were similar (as detailed in table 4 and discussed further in the supplementary material, available online only) (category Ib).

Overall, the highest availability of LPGs (100 %) and the lowest of IBs (11.5 %) were observed at primary healthcare facilities, whereas the IBs were most available (36.8 %) and LPGs least available (32.6 %) at secondary and tertiary facilities.

Among available serologic tests, the immunoblot (IB) assay that uses bovine hydatid cyst fluid (IBCF) has been successfully used in CE-endemic areas of Peru (12, 14 ).

For IBs, however, only 11.5 % were available in primary facilities, and only four medicines Amlodipine, Captopril, Ciprofloxacin and Metformin had >50%% availability.> -wrap-foot> Innovator Brand LPG Lowestowest Priced Generic The data also showed that the mean availability of LPGs and IBs was 32.6 % and 36.8 %, respectively, in secondary and tertiary facilities.

Of the 22 carcinomas where staging data was available, 36% were stage IA, 23% stage IB, 9% stage IIB, 23% stage III or IV and 9% unclassified.